Acurx Pharmaceuticals Ownership | Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals Ownership Summary

Acurx Pharmaceuticals is owned by 8.62% institutional investors, 13.20% insiders, and 78.18% retail investors. Vanguard group is the largest institutional shareholder, holding 3.23% of ACXP shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.97% of its assets in Acurx Pharmaceuticals shares.

ACXP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Acurx Pharmaceuticals	8.62%	13.20%	78.18%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	529.35K	3.23%	$430.89K
Prospect financial services	329.08K	2.01%	$267.87K
Geode capital management	146.50K	0.90%	$119.27K
Morgan stanley	46.40K	0.30%	$104.40K
Susquehanna group, llp	48.37K	0.30%	$39.38K
State street	43.47K	0.27%	$35.38K
Blackrock	27.50K	0.18%	$61.88K
Northern trust	27.29K	0.18%	$61.39K
Virtu financial	27.84K	0.17%	$23.00K
Blackrock funding, inc. /de	25.91K	0.16%	$21.09K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Prospect financial services	329.08K	0.15%	$267.87K
Semmax financial advisors	5.88K	0.00%	$11.17K
Nbc securities	19.00	0.00%	$15.00
Virtu financial	27.84K	0.00%	$23.00K
Patriot financial group insurance agency	10.38K	0.00%	$8.45K
Cornerstone planning group	3.34K	0.00%	$2.81K
Tower research capital llc (trc)	4.45K	0.00%	$3.62K
Gps wealth strategies group	500.00	0.00%	$407.00
Td waterhouse canada	18.66K	0.00%	$14.93K
Advisor group	14.18K	0.00%	$25.93K

Top Buyers

Holder	Shares	% Assets	Change
Susquehanna group, llp	48.37K	-	48.37K
Prospect financial services	329.08K	0.15%	34.00K
Virtu financial	27.84K	0.00%	27.84K
Morgan stanley	46.40K	-	20.00K
Cambridge investment research advisors	17.75K	-	17.75K

Top Sellers

Holder	Shares	% Assets	Change
Lpl financial	-	-	-44.78K
Act advisors, llc.	-	-	-21.28K
Nbc securities	19.00	0.00%	-18.98K
Xtx topco	-	-	-13.04K
Two sigma investments, lp	-	-	-12.99K

New Positions

Holder	Shares	% Assets	Change	Value
Susquehanna group, llp	48.37K	-	48.37K	$39.38K
Virtu financial	27.84K	0.00%	27.84K	$23.00K
Renaissance	14.67K	-	14.67K	$11.95K
Squarepoint ops	12.54K	-	12.54K	$10.21K
Northwestern mutual wealth management	1.64K	-	1.64K	$3.68K

Sold Out

Holder	Change
Wells fargo & company/mn	-87.00
Simplex trading	-1.16K
Tocqueville asset management	-10.00K
Two sigma investments, lp	-12.99K
Xtx topco	-13.04K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	27	17.39%	1,410,919	13.03%	8	14.82%	13	116.67%	4	-33.33%
Sep 30, 2024	23	-11.54%	1,248,314	3.50%	7	12.55%	6	-45.45%	6	50.00%
Jun 30, 2024	26	-3.70%	1,206,131	-3.41%	7	8.03%	11	-35.29%	4	33.33%
Mar 31, 2024	27	8.00%	1,248,676	14.30%	9	13.97%	17	-10.53%	3	200.00%
Dec 31, 2023	25	47.06%	1,092,462	24.40%	8	16.18%	19	58.33%	1	-66.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	384.36K	1.97%	551.00
Vanguard Total Stock Mkt Idx Inv	383.81K	1.96%	-
Vanguard Institutional Extnd Mkt Idx Tr	145.54K	0.75%	-
Fidelity Extended Market Index	74.58K	0.34%	-475.00
iShares Micro-Cap ETF	30.76K	0.14%	-
Northern Trust Extended Eq Market Idx	18.93K	0.10%	-
NT Ext Equity Mkt Idx Fd - L	18.93K	0.10%	-
Fidelity Total Market Index	20.03K	0.09%	-
Fidelity Series Total Market Index	18.30K	0.08%	-
Spartan Extended Market Index Pool F	15.11K	0.08%	475.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 06, 2025	Scodari Joseph C	-	Buy	$25.00K
Jan 06, 2025	Scodari Joseph C	-	Buy	$22.17K
Jan 06, 2025	Sailer Carl	-	Buy	$25.00K
Jan 06, 2025	Sailer Carl	-	Buy	$22.17K
Jan 06, 2025	LUCI DAVID P	President and CEO	Buy	$50.00K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	12	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q2	-	-

ACXP Ownership FAQ

Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals shareholders are primarily institutional investors at 8.62%, followed by 13.20% insiders and 78.18% retail investors. The average institutional ownership in Acurx Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Acurx Pharmaceuticals falls below.

Who owns the most shares of Acurx Pharmaceuticals?

Acurx Pharmaceuticals’s largest shareholders are Vanguard group (529.35K shares, 3.23%), Prospect financial services (329.08K shares, 2.01%), and Geode capital management (146.5K shares, 0.90%). Together, they hold 6.14% of Acurx Pharmaceuticals’s total shares outstanding.

Does Blackrock own Acurx Pharmaceuticals?

Yes, BlackRock owns 0.18% of Acurx Pharmaceuticals, totaling 27.5K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 61.88K$. In the last quarter, BlackRock increased its holdings by 8.82K shares, a 47.17% change.

Who is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Prospect financial services is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.15% of its assets in 329.08K Acurx Pharmaceuticals shares, valued at 267.87K$.

Who is the top mutual fund holder of Acurx Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Acurx Pharmaceuticals shares, with 1.97% of its total shares outstanding invested in 384.36K Acurx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools